- Jul 17, 2023
Survival of children with acute lymphatic leukemia has increased to 94%, study finds
The five-year survival of all children with acute lymphatic leukemia (ALL) has continued to increase to 94%. This is evident from a...
- Jul 7, 2023
BDR Pharma launches new drug for Philadelphia chromosome-positive leukemia
BDR Pharmaceuticals on Wednesday announced the launch of Nilotinib for a rare subtype of the most common childhood cancer, acute...
- May 2, 2023
Immunotherapy improves the prognosis of babies with a very aggressive leukemia
A trial with thirty patients under one year of age confirms that adding a bispecific antibody to the chemotherapy treatment increases...
- Mar 29, 2023
Rutgers researchers show importance of low vitamin A levels as harbinger of adverse event
Scientists seeking a way to eliminate an adverse reaction to treatments for acute lymphocytic leukemia, a common childhood cancer, have...
- Jan 18, 2023
Colin Seaman is the boy with the Harry Potter cells
"While developing a treatment plan, Lee introduced the family to a revolutionary treatment option for some patients with leukemia....
- Jan 6, 2023
Drug Response Study of Leukemia Subtypes Advances Precise Patient-Therapy Matching
A study by researchers at St. Jude Children’s Research Hospital delving into drug response across a swath of genetic subtypes of acute...
- Dec 28, 2022
Twin study confirms childhood leukaemia starts in the womb
By studying rare cases of identical twins with leukaemia, scientists have shed new light on the origins of the most common type of...
- Oct 14, 2022
Landmark study finds new gene mutations that drive acute lymphoblastic leukemia (ALL)
St. Jude scientists helped lead a comprehensive genomic analysis to uncover the impact of genes on the treatment and outcome of the...